SEC Filing Details

Document Details

Form
DRS
Filing Date
July 29, 2022
Document Date
July 29, 2022
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
TransCode Therapeutics
Issuer
TRANSCODE THERAPEUTICS, INC.